Molecular Formula | C26H35F3O6 |
Molar Mass | 500.55 |
Density | 1.245±0.06 g/cm3(Predicted) |
Boling Point | 584.8±50.0 °C(Predicted) |
Specific Rotation(α) | D20 +14.6° (c = 1.0 in methylene chloride) |
Flash Point | 17°C |
Solubility | Dichloromethane (Sparingly, Sonicated), Chloroform (Sparingy), Methanol (Sparing |
Vapor Presure | 1.61E-14mmHg at 25°C |
Appearance | ethanol solution |
Color | Colourless to Light Beige |
pKa | 13.43±0.20(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
Stability | Light Sensitive |
Refractive Index | 1.547 |
Risk Codes | R11 - Highly Flammable R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S16 - Keep away from sources of ignition. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S7 - Keep container tightly closed. |
UN IDs | UN 1170 3/PG 2 |
WGK Germany | 1 |
HS Code | 2937500000 |
colorless to pale yellow oil. Very soluble in acetonitrile, methanol, octanol or chloroform, almost insoluble in water.
7-[(1R,2R.3R,5S)-3,5 -- hydroxy 2 A [(3S) a 4 (3 trifluoromethyl phenoxy) the product is obtained by esterification of 3-hydroxy-1e-pentenyl] cyclopentyl l-52-heptenoic acid with isopropanol.
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.998 ml | 9.989 ml | 19.978 ml |
5 mM | 0.4 ml | 1.998 ml | 3.996 ml |
10 mM | 0.2 ml | 0.999 ml | 1.998 ml |
5 mM | 0.04 ml | 0.2 ml | 0.4 ml |
developed by Alcon, Inc., USA, was first launched in the United States in March 2001. Prostaglandin F2-a stimulant, intraocular pressure lowering drug. It is used to treat patients with open angle glaucoma or ocular hypertension who are not effective or cannot tolerate other intraocular pressure lowering drugs.